EVEON is announcing that it has forged a partnership with a pharmaceutical laboratory for a development based on the innovative Intuity® Ject medical device, recipient of a 2017 Pharmapack Award.

EVEON contributes to microfluidic standards development by participating in the design and use of a modular R&D platform using standardized components. Work on this subject has been published in the magazine Sensors and Actuators B: Chemical.

EVEON and six French companies have sealed a unique partnership called JBT HubUp a unique solution for developing innovative medical devices.

To optimize its fluidic processes, EVEON has collaborated for several years with the laboratory LMGP to understand the causes of the aggregation during the manipulation of proteins. Work on this subject has been published in the magazine Langmuir.

A EVEON was awarded the special prize Ease of use and Patient compliance in the Best Innovation Exhibitor category at Pharmapack Europe 2017 for its Intuity® Ject device.

EVEON announces the release of its new prototype, which reconstitutes lyophilised drugs in just two steps, with no handling or contact with the product.

STMicroelectronics Grenoble and EVEON have signed a partnership agreement aimed at supplying components to be used in new generation medical devices developed by EVEON that will respond to the growing demand for injectable biological treatments.

EVEON gave a presentation at 2016 PDA Europe Advanced Therapy Medicinal Products (ATMPs) Conference, on June 7-8, in Berlin (Germany).

EVEON was presented, in february 2016, with a Pharmapack Europe Award for its device Intuity® Lyo¹ with the special distinction "Convenience and Easy of use".